Table 2.
Location | Experiment | Layer | Size (µm) |
---|---|---|---|
Perirhinal Area 36 | |||
Rostrodorsal area 36 | 120 FB | III–V | 700 |
Rostroventral area 36 | 97 DY | III–V | 500 |
Midrostrocaudal area 36 | 98 DY | I–V | 300 |
Midrostrocaudal area 36 | 132 DY | V | 200 |
Midrostrocaudal area 36 | 94 FB | V | 400 |
Caudoventral area 36 | 199 DY | II–III | 300 |
Caudoventral area 36 | 100 DY | V | 300 |
Caudodorsal area 36 | 120 DY | V | 300 |
Perirhinal Area 35 | |||
Rostral area 35 | 102 DY | I–V | 400 |
Rostroventral area 35 | 132 FB | V–VI | 300 |
Ventral area 35 | 112 DY | V | 400 |
Caudal area 35 | 2108 FG | I–VI | 300 |
Postrhinal | |||
Rostral POR | 97 FB | V | 400 |
Rostroventral POR | 102 FB | V | 200 |
Middle POR | 98 FB | I–VI | 600 |
Caudodorsal POR | 100 FB | I–V | 500 |
Caudal POR | 95 DY | III–VI | 400 |
Caudal POR | 99 FB | I–V | 500 |
Entorhinal LEA | |||
Rostrolateral LEA, L | 113 FB | I–V | 600 |
Caudolateral LEA, L | 130 FB | V–VI | 400 |
Rostral LEA, I | 124 FB | I–VI | 800 |
Caudal LEA, I | 105 DY | V | 400 |
Caudal LEA, I | 128 DY | V | 300 |
Caudomedial LEA, I | 105 FB | III–VI | 400 |
Medial LEA, I | 129 FB | V–VI | 300 |
Rostral LEA, M | 129 DY | III–V | 300 |
Entorhinal MEA | |||
Lateral MEA, L | 113 DY | V | 300 |
Lateral MEA, L | 118 FB | III–VI | 600 |
Caudomedial MEA, L | 124 DY | I–V | 600 |
Caudal MEA, I | 119 DY | I–V | 400 |
Medial MEA, M | 106 DY | II–VI | 500 |
Medial MEA, M | 128 FB | V | 300 |
Retrograde injections sites are suffixed with a FB, DY, or FG for Fast Blue, Diamidino Yellow, or Fluorogold, respectively.
For experiment 99DY, the injection site was excluded from analyses as there was negligible labeling due to superficial location of site.
Experiment 108 FG encroached slightly on LEA. Other abbreviations: L, lateral dentate gyrus-projecting band; I, intermediate band; M, medial band.